Meta-analysis: Don't do what I did

EuroIntervention

Volumn 12, Issue 5, 2016, Pages e535-

  Serruys, Patrick W ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

TRAPIDIL;

CLINICAL PRACTICE; CLINICAL STUDY; DRUG EFFICACY; EDITORIAL; EVIDENCE BASED MEDICINE; HUMAN; IN-STENT RESTENOSIS; INFORMATION PROCESSING; MATHEMATICAL PHENOMENA; META ANALYSIS (TOPIC); OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICAL ANALYSIS; CLINICAL TRIAL (TOPIC); PATIENT; PUBLICATION;

CLINICAL TRIALS AS TOPIC; HUMANS; META-ANALYSIS AS TOPIC; PATIENTS; STUDY GUIDE AS TOPIC;

EID: 84983802351     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV12I5A90     Document Type: Editorial

References (2)

1. Serruys PW, Banz K, Darcis T, Mignot A, van Es GA, Schwicker D. Results of a Meta-Analysis of Trapidil, a PDGF Inhibitor: A Sufficient Reason for a Second Look to the Pharmacological Approach to Restenosis. J Invasive Cardiol. 1997;9:505-512.
2. Serruys PW, Foley DP, Pieper M, Kleijne JA, de Feyter PJ; TRAPIST investigators. The TRAPIST Study. A multicentre randomized placebo controlled clinical trial of trapidil for prevention of restenosis after coronary stenting, measured by 3-D intravascular ultrasound. Eur Heart J. 2001;22:1938-47. Erratum in: Eur Heart J. 2002;23:1066.